Brief: Glenmark Pharmaceuticals Says USA Unit Agrees To $37.75 Million Settlement
06/08/2025 16:29
Aug 6 (Reuters) - Glenmark Pharmaceuticals Ltd GLEN.NS: GLENMARK PHARMACEUTICALS LTD - USA UNIT AGREES TO $37.75 MILLION SETTLEMENT GLENMARK PHARMACEUTICALS LTD - USA UNIT DENIES ALLEGATIONS, SETTLEMENT NOT AN ADMISSION Source text: ID:nBSE8kpWC5 Further company coverage: GLEN.NS ((reuters.briefs@thomsonreuters.com;))
Recent news on Glenmark Pharmaceuticals
See all newsBrief: Glenmark Pharma Says Unit Launches Ryaltris Nasal Spray In Brazil For Allergic Rhinitis
Brief: Glenmark Pharma US Unit Launches Calcium Gluconate Injection USP In Multiple Vial Sizes
India's Glenmark Pharma gains most in three weeks on US approval for Flonase nasal spray
Brief: Glenmark Pharma Gets U.S. FDA Approval For Fluticasone Propionate Nasal Spray 0.05 Mg/Spray
India's Glenmark Pharmaceuticals falls as brokerage flags softer-than-expected quarter